Get the app
US › Healthcare

Inogen Inc (INGN)

US · Healthcare · Medical Devices

$6.25-0.71%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$95.1M
Revenue YoY
+3.0%
Net profit
$-3.9M
EPS
$-0.14
EPS estimate
$-0.17
Net margin
-4.0%

EPS came in at -0.14 against a street estimate of -0.17 — a beat of 17.6%.

Key statistics

Market cap
$162.7M
Forward P/E
0.0
P/B
0.77
Book value
$6.54
EPS (TTM)
$-0.89
52-week high
$9.13
52-week low
$5.04
50-day MA
$5.61
200-day MA
$6.22
Beta
1.50

Analyst view

Analysts rate Inogen Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $12.00.

Shareholding

Insiders
12.95%
Institutions
80.31%

Largest institutional holders

FundStake
BlackRock Inc6.59%
Acadian Asset Management LLC4.13%
Armistice Capital, LLC4.13%
Vanguard Capital Management, LLC3.91%
Ameriprise Financial Inc3.70%
AQR Capital Management LLC3.53%
Dafna Capital Management LLC3.18%
Arrowstreet Capital Limited Partnership2.80%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Inogen Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.